Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma
Ting Sun, Hongchun Liu, Liang Ming
Cellular Physiology and Biochemistry (2017) Vol. 44, Iss. 2, pp. 716-727
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma
Fang Huang, Bing-Rong Wang, Yigang Wang
World Journal of Gastroenterology (2018) Vol. 24, Iss. 41, pp. 4643-4651
Open Access | Times Cited: 178
Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells
Lijun Liang, Kaiyuan Hui, Chenxi Hu, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 153
Progress on Ras/MAPK Signaling Research and Targeting in Blood and Solid Cancers
Martha Dillon, Antonio R. Lopez, Edward H. Lin, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5059-5059
Open Access | Times Cited: 106
The role of autophagy in resistance to targeted therapies
Luigi Mele, Vitale Del Vecchio, Davide Liccardo, et al.
Cancer Treatment Reviews (2020) Vol. 88, pp. 102043-102043
Open Access | Times Cited: 131
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
Loraine Kay D. Cabral, Claudio Tiribelli, Caecilia Sukowati
Cancers (2020) Vol. 12, Iss. 6, pp. 1576-1576
Open Access | Times Cited: 129
Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy
Ting Liu, Jing Zhang, Kangdi Li, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 103
RETRACTED: Combination of aloin and metformin enhances the antitumor effect by inhibiting the growth and invasion and inducing apoptosis and autophagy in hepatocellular carcinoma through PI3K/AKT/mTOR pathway
Ruijie Sun, Ruiren Zhai, Changlin Ma, et al.
Cancer Medicine (2019) Vol. 9, Iss. 3, pp. 1141-1151
Open Access | Times Cited: 93
Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma
Chandramohan Kiruthiga, Kasi Pandima Devi, Seyed Mohammad Nabavi, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 562-562
Open Access | Times Cited: 73
Enhancing autophagy in Alzheimer's disease through drug repositioning
Mehdi Eshraghi, Mazaher Ahmadi, Saeid Afshar, et al.
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108171-108171
Closed Access | Times Cited: 67
Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-κB pathways and LncRNA-AF085935/GPC3 axis
Tohada M. AL‐Noshokaty, Noha M. Mesbah, Dina M. Abo‐Elmatty, et al.
Life Sciences (2022) Vol. 303, pp. 120675-120675
Closed Access | Times Cited: 54
Global research status and frontiers on autophagy in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis
Tao He, Jieyu Zou, Ke Sun, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 10
Hypoxia induces sorafenib resistance mediated by autophagy via activating FOXO3a in hepatocellular carcinoma
Chao Liang, Zhebin Dong, Xianlei Cai, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 61
Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity
Jun Li, Baojun Duan, Ying Guo, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 98, pp. 806-812
Closed Access | Times Cited: 59
Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5
Chi‐Yuan Chen, Chih‐Cheng Chen, Tzong‐Ming Shieh, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 380-380
Open Access | Times Cited: 59
Sorafenib Inhibits Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in Hepatocellular Carcinoma Cells
Pei‐Ming Yang, Li-Shan Lin, Tsang-Pai Liu
Biomolecules (2020) Vol. 10, Iss. 1, pp. 117-117
Open Access | Times Cited: 54
G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer.
Masanori Oshi, Ankit Patel, Lan Le, et al.
PubMed (2021) Vol. 11, Iss. 6, pp. 3070-3084
Closed Access | Times Cited: 54
Challenges and Therapeutic Opportunities of Autophagy in Cancer Therapy
Valdenizia R. Silva, Sara P. Neves, Luciano de S. Santos, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3461-3461
Open Access | Times Cited: 53
Cell Death in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Opportunities
Ester García-Pras, Anabel Fernández‐Iglesias, Jordi Gracia‐Sancho, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 48-48
Open Access | Times Cited: 47
Inhibition of Cyclin‐Dependent Kinase 5: A Strategy to Improve Sorafenib Response in Hepatocellular Carcinoma Therapy
Maximilian A. Ardelt, Thomas Fröhlich, Emanuele Martini, et al.
Hepatology (2018) Vol. 69, Iss. 1, pp. 376-393
Open Access | Times Cited: 50
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α
Yongxin Qiu, Wenqi Shan, Ye Yang, et al.
Cell Death Discovery (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 47
Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4
Zhongrong Guo, Wen Chen, Guisen Dai, et al.
International Journal of Molecular Medicine (2019)
Open Access | Times Cited: 43
MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24
Zongqiang Hu, Yingpeng Zhao, Yuanyi Mang, et al.
Life Sciences (2023) Vol. 325, pp. 121773-121773
Open Access | Times Cited: 14
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 5
c-FLIP/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma
Yasamin Haghir-Sharif-Zamini, Arezoo Khosravi, Moustapha Hassan, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110306-110306
Closed Access
Machine learning and molecular subtyping reveal the impact of diverse patterns of cell death on the prognosis and treatment of hepatocellular carcinoma
Xinyue Yan, Meng Wang, L. Min Ji, et al.
Computational Biology and Chemistry (2025) Vol. 115, pp. 108360-108360
Closed Access
Page 1 - Next Page

Scroll to top